Report Categories
View AllRecent Articles
View All
CRSP CRISPR Therapeutics AG Common Shares gains 407 percent despite posting a wider than expected Q4 2025 per share loss
IPSC Century Therapeutics Inc posts narrower Q4 2025 loss than expected shares gain 656 percent in daily trading
Kopin Corporation KOPN Stock Forecast Q4 2025 EPS Tops Views
What Globalstar GSAT is doing to protect its market share Investor Concern 20260507
How Gabelli GCV performance compares to expectations Tick Up 20260508
Why Cyclerion CYCN deserves a deeper look right now 278 20260507
HAE Haemonetics Corporation reports Q1 2026 EPS beat as shares rise 243 percent on 4 percent year over year revenue growth